WuXi Biologics Enters into an Agreement with Terumo on Leverkusen DP Plant
Leverkusen, Germany --WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has entered into an agreement with Terumo Corporation that Terumo will take over WuXi Biologics’ drug product (DP) plant in Leverkusen, Germany for EUR 150 million. The transaction is expected to be concluded in 2025, subject to the satisfaction of customary closing conditions.
Divesting the Leverkusen facility is a strategic step in aligning with the company’s long-term growth to enhance agility, scale diversified solutions for its global clients, and address emerging needs worldwide. This decision will allow WuXi Biologics to exclusively focus on building large-scale global DP manufacturing capacities in Singapore while optimizing returns on assets for future growth.
As a result, WuXi Biologics has completed the strategic review of all sites and will focus on building and developing its current sites.
Related parks
Categories
Companies
Latest news
NEXTCHEM awarded a feasibility study by Mana Group and Equinor for the production of sustainable fuels in Norway leveraging its NX Circular™ technology
With the support of NEXTCHEM, Mana (NG Nordic) and Equinor are entering an early-stage strategic partnership to explore the potential development of the Nordics' first large-scale waste-to-methanol...
A circular economy pioneer
REMONDIS' Lippe Plant →Founded back in 1991, RETERRA has transformed itself from a regional composting business into a nationwide biomass management specialist.
ECLUSE Scheldt Tunnel Completed: Belgium’s longest microtunnel is now a reality
Port Of Antwerp →Work on extending the ECLUSE steam network from the left to the right bank of the Scheldt has reached a major milestone. The tunnel that will carry the pipelines beneath the river has now been comp...
PureCycle Receives REACH Certification, Unlocking EU Sales of PureFive™ Resin
Port Of Antwerp →PureCycle Technologies has received the REACH Certificate of Compliance, allowing the Company to sell PureFive™ resin to customers in the European Union. PureCycle has plans to build its first Euro...